Mixture distribution analysis of phenotypic markers reflecting HFE gene mutations

Blood

Volumn 102, Issue 13, 2003, Pages 4563-4566

  McLaren, Christine E ^a   Li, Kuo Tung ^b   Garner, Chad P ^b   Beutler, Ernest ^b   Gordeuk, Victor R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; TRANSFERRIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HFE GENE; HOMOZYGOSITY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 0344737638     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-04-1278     Document Type: Article

References (30)

1. Adams PC, Gregor JC, Kertesz AE, et al. Screening blood donors for hereditary hemochromatosis: decision and analysis model based on a 30-year database. Gastroenterology. 1995;109:177-188.
2. Witte DL, Crosby WH, Edwards CQ, et al. Practice Guideline Development Task Force of the College of American Pathologists: hereditary hemochromatosis. Clin Chim Acta. 1996;245:139-200.
3. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
4. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA. 1998;280:172-178.
5. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In: Brock JH, Halliday JW, Pippard MJ, et al, eds. Iron Metabolism in Health and Disease. Philadelphia, PA: WB Saunders; 1994:247-254.
6. McLaren CE, Gordeuk VR, Looker AC, et al. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood. 1995;86:2021-2027.
7. McLaren CE, McLachlan GJ, Halliday JW, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology. 1998;114:543-549.
8. McLaren CE, Li KT, Gordeuk VR, et al. Relationship between transferrin saturation and iron stores in the African American and US caucasian populations: analysis of data from the third National Health and Nutrition Examination Survey. Blood. 2001;98:2345-2351.
9. Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000;133:329-337.
10. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G>A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211-218.
11. Finch CA, Deubelbeiss K, Cook JD, et al. Ferrokinetics in man. Medicine. 1970;49:17-53.
12. Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Br J Haematol. 1978;40:255-263.
13. Cartwright GE, Wintrobe MM. Chemical, clinical, and immunological studies on the products of human plasma fractionation, XXXIX: the anemia of infection: studies on the iron-binding capacity of serum. J Clin Invest. 1949;28:86-98.
14. Jandl JH. Blood. Boston, MA: Little, Brown & Co; 1987.
15. Bainton DF, Finch CA. The diagnosis of iron deficiency anemia. Am J Med. 1964;37:62-70.
16. Edwards CQ, Griffen LM, Kaplan J, Kushner JP. Twenty-four-hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes. J Intern Med. 1989;226:173-179.
17. Gordeuk VR, Brittenham GM, McLaren GD, Spagnuolo PJ, Hyperferremia in immmunosuppressed patients with acute nonlymphocytic leukemia and the risk of infection. J Lab Clin Med. 1986;108:466-472.
18. Barton JC, Bertoli LF, Rothenberg BE. Peripheral blood erythrocyte parameters in hemochromatosis: evidence for increased erythrocyte hemoglobin content. J Lab Clin Med. 2000;135:96-104.
19. Gordeuk VR, McLaren CE, Looker AC, Hasselblad V, Brittenham GM. Distribution of transferrin saturations in the African-American population. Blood. 1998;91:2175-2179.
20. Hasselblad V. Manual for the grouped DISFIT software, version 1.1. Durham, NC: Duke University; 1992.
21. McLachlan GJ, Krishnan T. The EM Algorithm and Extensions. New York, NY: John Wiley & Sons; 1997.
22. McLachlan GJ, Basford KE. Mixture Models: Inference and Applications to Clustering. New York, NY: Marcel Dekker; 1988.
23. Crump KS, Howe R. A preview of methods for calculating confidence limits in low dose extrapolation. In: Krewski D, ed. Toxicological Risk Assessment. Boca Raton, FL: CRC Press; 1985:188-203.
24. Expert Scientific Working Group. Summary of a report on assessment of the iron nutritional status of the United States population. Am J Clin Nutr. 1985;42:1318-1330.
25. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. Association of age, sex, and race with body iron stores in adults: analysis of NHANES III data. Am Heart J. 2000;140:98-104.
26. Cuzick J. Trend tests. In: Kotz S, Johnson N, eds. Encyclopedia of Statistical Sciences. Vol 9. New York, NY: John Wiley & Sons; 1988:336-342.
27. Spriggs EL, Harris PE, Best LG. Hemochromatosis mutations C282Y and H63D in "cis" phase. Clin Genet. 2001;60:68-72.
28. Lucotte G, Champenois T, Semonin O. A rare case of a patient heterozygous for the hemochromatosis mutation C282Y and homozygous for H63D. Blood Cells Mol Dis. 2001;27:892-893.
29. Waalen J, Felitti V, Gelbart T, Ho NJ, Beutler E. Prevalence of hemochromatosis-related symptoms in homozygotes for the C282Y mutation of the HFE gene. Mayo Clin Proc. 2002;77:522-530.
30. Guo X, Rotimi C, Cooper R, et al. Evidence of a major gene effect for angiotensinogen among Nigerians. Ann Hum Genet. 1999;63:293-300.